UPR Stock Overview
Operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Uniphar plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.00 |
| 52 Week High | €3.00 |
| 52 Week Low | €1.97 |
| Beta | 0.80 |
| 1 Month Change | -4.53% |
| 3 Month Change | -23.66% |
| 1 Year Change | -23.66% |
| 3 Year Change | -58.51% |
| 5 Year Change | 66.11% |
| Change since IPO | 70.94% |
Recent News & Updates
The Price Is Right For Uniphar plc (ISE:UPR)
Nov 16
Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Recent updates
The Price Is Right For Uniphar plc (ISE:UPR)
Nov 16Analysts Are Updating Their Uniphar plc (ISE:UPR) Estimates After Its Half-Year Results
Sep 06Here's Why Shareholders May Want To Be Cautious With Increasing Uniphar plc's (ISE:UPR) CEO Pay Packet
May 03Is There An Opportunity With Uniphar plc's (ISE:UPR) 37% Undervaluation?
Apr 20Investors Met With Slowing Returns on Capital At Uniphar (ISE:UPR)
Jan 31Uniphar plc's (ISE:UPR) 25% Jump Shows Its Popularity With Investors
Dec 18These 4 Measures Indicate That Uniphar (ISE:UPR) Is Using Debt Reasonably Well
Nov 18The Returns At Uniphar (ISE:UPR) Aren't Growing
Sep 20Uniphar (ISE:UPR) Is Experiencing Growth In Returns On Capital
May 12The Uniphar plc (ISE:UPR) Full-Year Results Are Out And Analysts Have Published New Forecasts
Mar 03Estimating The Intrinsic Value Of Uniphar plc (ISE:UPR)
Dec 16Here's Why We Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Nov 24An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 45% Undervalued
Aug 01What Does Uniphar plc's (ISE:UPR) Share Price Indicate?
Jul 20Some Investors May Be Worried About Uniphar's (ISE:UPR) Returns On Capital
May 27An Intrinsic Calculation For Uniphar plc (ISE:UPR) Suggests It's 33% Undervalued
Apr 29Uniphar (ISE:UPR) Seems To Use Debt Quite Sensibly
Apr 02Here's Why I Think Uniphar (ISE:UPR) Might Deserve Your Attention Today
Mar 18Uniphar (ISE:UPR) Might Be Having Difficulty Using Its Capital Effectively
Feb 13Is Uniphar (ISE:UPR) A Risky Investment?
Dec 23Here's Why I Think Uniphar (ISE:UPR) Is An Interesting Stock
Oct 30Uniphar's (ISE:UPR) Returns On Capital Not Reflecting Well On The Business
May 14Uniphar (ISE:UPR) Has A Pretty Healthy Balance Sheet
Mar 10Does Uniphar's (ISE:UPR) Share Price Gain of 83% Match Its Business Performance?
Feb 23Will The ROCE Trend At Uniphar (ISE:UPR) Continue?
Feb 02Is Weakness In Uniphar plc (ISE:UPR) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Jan 15Trade Alert: The CEO & Executive Director Of Uniphar plc (ISE:UPR), Gerard Rabbette, Has Just Spent €900k Buying 4.2% More Shares
Dec 24
Do Institutions Own Uniphar plc (ISE:UPR) Shares?
Dec 23Is Uniphar (ISE:UPR) Using Too Much Debt?
Dec 03Uniphar (ISE:UPR) Shareholders Have Enjoyed A 91% Share Price Gain
Nov 18Shareholder Returns
| UPR | IE Healthcare | IE Market | |
|---|---|---|---|
| 7D | -4.8% | -2.7% | -1.4% |
| 1Y | -23.7% | 1.9% | 4.5% |
Return vs Industry: UPR underperformed the Irish Healthcare industry which returned 1.9% over the past year.
Return vs Market: UPR underperformed the Irish Market which returned 4.5% over the past year.
Price Volatility
| UPR volatility | |
|---|---|
| UPR Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in IE Market | 8.0% |
| 10% least volatile stocks in IE Market | 2.8% |
Stable Share Price: UPR has not had significant price volatility in the past 3 months compared to the Irish market.
Volatility Over Time: UPR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Uniphar plc Fundamentals Summary
| UPR fundamental statistics | |
|---|---|
| Market cap | €546.03m |
| Earnings (TTM) | €45.17m |
| Revenue (TTM) | €2.68b |
12.1x
P/E Ratio0.2x
P/S RatioIs UPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UPR income statement (TTM) | |
|---|---|
| Revenue | €2.68b |
| Cost of Revenue | €2.27b |
| Gross Profit | €408.69m |
| Other Expenses | €363.52m |
| Earnings | €45.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.17 |
| Gross Margin | 15.24% |
| Net Profit Margin | 1.68% |
| Debt/Equity Ratio | 68.5% |
How did UPR perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield11%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Uniphar plc is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Calum Battersby | Berenberg |
| Eoghan Reid | Berenberg |
| Samuel England | Berenberg |